Grant: Project Grant - Priority Announcement: Cancer Research
McMaster University
$100,000.00
Structural Basis of Cyclic Nucleotide Signal Translation
FY 2022-23
Summary
High blood pressure is a major risk factor for heart failure, angina pectoris, and stroke and is often caused by defective reading of a cellular signal transmitted by a second messenger called cyclic guanosine monophosphate or cGMP. Dysfunctional cGMP signaling also results in life-threatening ruptures of the aorta, one of the blood vessels that connects the heart to the rest of the body. In addition, defective reading of a closely related molecule, cyclic adenosine monophosphate (cAMP) causes a general predisposition for pancreatic, endocrine, and cardiac tumors as well as intellectual disabilities and abnormal bone growth in children. The long-term goal of this project is to study two proteins that bind to cGMP and cAMP, i.e. the cGMP-dependent protein kinase G (PKG) and cAMP-dependent protein kinase A (PKA), and elucidate the structural and dynamical changes caused by inherited disease-causing mutations that lead to incorrect translation of the cGMP and cAMP signal. We will also investigate how drug leads currently in development for such diseases work. For example, pharmacological nitroxyl (HNO) donors are effective in reducing blood pressure by mimicking the effect of cGMP on PKG. However, further mechanistic understanding is needed to improve current treatments. To this end, we will rely on nuclear magnetic resonance (NMR) spectroscopy. NMR is ideally suited to reveal how cAMP, cGMP, their analogs, and HNO donors modify the structure and dynamics of PKA and PKG, as needed to understand how to modulate these proteins' activities. NMR is also ideal to unveil how disease-causing inherited mutations alter the physiological interactions of PKA and PKG with cAMP and cGMP, respectively. Elucidating the structural and dynamical changes caused by disease-related mutations and drug leads will help understand the molecular origins of multiple cardiovascular diseases, tumors, and pediatric disorders, and will facilitate the design of improved treatments.
Department
Program
Project Grant - Priority Announcement: Cancer Research
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
472447
Name
Melacini Giuseppe
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Biochemistry & Molecular Biology - A
Projecttitle
Structural Basis of Cyclic Nucleotide Signal Translation
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Cancer Research
Keyworddelim
Acrodysostosis; Allostery; Aneurysm; Camp; Carney Complex; Cgmp; Dynamics; Nuclear Magnetic Resonance (Nmr); Protein Kinase; Signalling
Abstract
High blood pressure is a major risk factor for heart failure, angina pectoris, and stroke and is often caused by defective reading of a cellular signal transmitted by a second messenger called cyclic guanosine monophosphate or cGMP. Dysfunctional cGMP signaling also results in life-threatening ruptures of the aorta, one of the blood vessels that connects the heart to the rest of the body. In addition, defective reading of a closely related molecule, cyclic adenosine monophosphate (cAMP) causes a general predisposition for pancreatic, endocrine, and cardiac tumors as well as intellectual disabilities and abnormal bone growth in children. The long-term goal of this project is to study two proteins that bind to cGMP and cAMP, i.e. the cGMP-dependent protein kinase G (PKG) and cAMP-dependent protein kinase A (PKA), and elucidate the structural and dynamical changes caused by inherited disease-causing mutations that lead to incorrect translation of the cGMP and cAMP signal. We will also investigate how drug leads currently in development for such diseases work. For example, pharmacological nitroxyl (HNO) donors are effective in reducing blood pressure by mimicking the effect of cGMP on PKG. However, further mechanistic understanding is needed to improve current treatments. To this end, we will rely on nuclear magnetic resonance (NMR) spectroscopy. NMR is ideally suited to reveal how cAMP, cGMP, their analogs, and HNO donors modify the structure and dynamics of PKA and PKG, as needed to understand how to modulate these proteins' activities. NMR is also ideal to unveil how disease-causing inherited mutations alter the physiological interactions of PKA and PKG with cAMP and cGMP, respectively. Elucidating the structural and dynamical changes caused by disease-related mutations and drug leads will help understand the molecular origins of multiple cardiovascular diseases, tumors, and pediatric disorders, and will facilitate the design of improved treatments.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Melacini, Giuseppe
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~